🚀 Per a recent report, the global AI for predictive healthcare market is experiencing rapid growth—rising from $8.85B in 2024 to $11.69B in 2025, and projected to reach nearly $48B by 2030. 

🤖 AI’s effectiveness is dependent on the quality of the data it is trained on. For AI tools used in healthcare, the quality, completeness, and representativeness of healthcare data are crucial. Reliable predictions require accurate, complete, and current patient data. 

🗃️Clinakos Inc. we make sure our patient-data is in its cleanest state, organized, with no data blocking and seamless integration across sources. 

📊Our Integrated Patient Data™ and Medically Smart AI™ platform provides high-fidelity, robust, regulatory-ready data for constructing detailed, longitudinal patient journeys by aggregating information from EHRs, EMRs, pharmacies, labs, and patient-generated sources.

 🩺This helps in understanding diagnosis, treatment patterns, adherence, and outcomes, especially in complex or rare diseases. 

🔍Through patient-centric AI-driven high fidelity data, we support product launches with precise patient segmentation and targeting, help study patient drop-off, discontinuation, and switching behaviors in near real time to improve adherence and persistence. 

 📊 Clinakos’ data transforms clinical research by providing richer, more actionable data, accelerating trial processes, and enabling smarter, data-driven decisions that improve patient outcomes, support innovative drug development and optimize commercialization.

 👉Reach out to us to learn more at https://lnkd.in/gp3gUmXc

👉Follow us at Clinakos Inc.

👉See the link to the original article here